Neutrophilic eccrine hidradenitis induced by cetuximab
Yükleniyor...
Dosyalar
Tarih
2012
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Informa Healthcare
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
Cetuximab is an epidermal growth factor receptor inhibitor used in metastatic colorectal cancer, and head and neck cancers. Several cutaneous side effects due to cetuximab such as acne-like rash, pruritus, dry skin, desquamation, hypertrichosis, and paronychia have been reported so far. A 59-year-old male patient with metastatic colon cancer referred to our outpatient clinic for his lesions on the dorsal surfaces of his hands and wrists, and on thighs developing after the chemotherapy. He was diagnosed as neutrophilic eccrine hydradenitis related to cetuximab in the light of clinical and histopathological findings. According to our knowledge, this is the first reported case of neutrophilic ecrine hydradenitis due to cetuximab.
Açıklama
oktay, murat/0000-0002-0893-4444; Kaya, Ertugrul/0000-0003-0081-682X
WOS: 000304093100011
PubMed: 22034841
WOS: 000304093100011
PubMed: 22034841
Anahtar Kelimeler
Cetuximab, epidermal growth factor, neutrophilic eccrine hidradenitis
Kaynak
Cutaneous And Ocular Toxicology
WoS Q Değeri
Q3
Scopus Q Değeri
Q3
Cilt
31
Sayı
2
